Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C
World Journal of Gastroenterology, 10/30/09
Sibulesky L et al. – Hepatitis C is the most common indication for orthotopic liver transplantation in the United States. Unfortunately, hepatitis C recurs universally in the transplanted liver and is the major cause of decreased graft and patient survival. The combination therapy of interferon and ribavirin has been shown to be the most effective therapy for recurrent hepatitis C.
Related Articles
De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
Liver Transplantation, 10/30/09
Relevance Score: 70%
FOXP3 Expression in Hepatitis C Virus-Specific CD4+ T Cells During Acute Hepatitis C
Gastroenterology, 10/06/09
Relevance Score: 70%
APRI as a predictor of early viral response in chronic hepatitis C patients
World Journal of Gastroenterology, 10/26/09
Relevance Score: 69%
Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial
Hepatology, 10/14/09
Relevance Score: 69%
The HLA-ER/HLA-ER Genotype Affects the Natural Course of Hepatitis C Virus (HCV) Infection and Is Associated with HLA-E–Restricted Recognition of an HCV-Derived Peptide by Interferon[gamma]–Secreting Human CD8+ T Cells
The Journal of Infectious Diseases, 10/14/09
Relevance Score: 69%
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Cutaneous Sarcoidosis: An Uncommon Side Effect of Pegylated Interferon and Ribavirin Use for Chronic Hepatitis C
Case Reports in Gastroenterology, 11/24/09
Factors That Influence an HIV Coinfected Patients Decision to Start Hepatitis C Treatment
AIDS Patient Care and STDs, 11/24/09
Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles
Journal of Virology, 11/24/09
Article Search
Sponsor


See Latest Articles


